Hikma Pharmaceutical reported $251M in Pre-Tax Profit for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Almirall ALM:SM EUR 13.9M 14.3M
Argen X Bv ARGX:BB USD -241024000 24.05M
AstraZeneca AZN:LN USD 3.09B 52M
Fresenius FRE:GR EUR 746M 17M
Genmab GEN:DC DKK 3.27B 783M
GlaxoSmithKline GSK:LN GBP 2.43B 602M
Hikma Pharmaceutical HIK:LN USD 251M 28M
Merck MRK:GR EUR 1.29B 108M
Orion ORNBV:FH EUR 244.6M 161.5M
Roche Holding ROG:VX 12.11B 2.43B